pmc logo image
Logo of jclinpathJournal of Clinical PathologyCurrent TOCInstructions for authors

Formats:

J Clin Pathol. 1984 January; 37(1): 1–5.
PMCID: PMC498607
Distribution of the Ca (Oxford) antigen in lung neoplasms and non-neoplastic lung tissues.
F J Paradinas, G Boxer, and K D Bagshawe
Abstract
The Ca (Oxford) antigen was originally isolated from a malignant neoplasm and with few exceptions was reported to discriminate between malignant and non-malignant neoplasms or normal tissues. Using the Ca 1 antibody we have studied the Ca distribution in 54 lung neoplasms and adjacent non-neoplastic lung tissue. Staining of tumours was very focal and the proportion of positive cells varied from about 50% for adenocarcinomas to less than 1% for oat cell carcinomas, which were often negative. Focal cytoplasmic staining can be seen in all neoplasms, whereas membrane staining is mainly seen in their areas of glandular and squamous differentiation. We found consistently strong membrane staining of alveolar type II pneumocytes in non-neoplastic lung. This staining may be useful in differentiating type II cells from alveolar macrophages which only occasionally showed granular cytoplasmic staining, probably due to phagocytosed Ca. Mucin from tumours and bronchi did not stain but there was consistent staining of alveolar serous exudate suggesting extracellular location of Ca.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 
Images in this article
Click on the image to see a larger version.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Ashall F, Bramwell ME, Harris H. A new marker for human cancer cells. 1 The Ca antigen and the Ca1 antibody. Lancet. 1982 Jul 3;2(8288):1–6. [PubMed]
  • McGee JO, Woods JC, Ashall F, Bramwell ME, Harris H. A new marker for human cancer cells, 2 immunohistochemical detection of the Ca antigen in human tissues with the Ca1 antibody. Lancet. 1982 Jul 3;2(8288):7–10. [PubMed]
  • Woods JC, Spriggs AI, Harris H, McGee JO. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody. Lancet. 1982 Sep 4;2(8297):512–514. [PubMed]
  • Burnett RA, Deery AR, Adamson MR, Liddle C, Thomas M, Roberts GH. Evaluation of Cal antibody in pleural biopsy material. Lancet. 1983 May 21;1(8334):1158. [PubMed]
  • Pallesen G, Jepsen FL, Hastrup J, Ipsen A, Hvidberg N. Experience with the Oxford tumour marker (Ca1) in serous fluids. Lancet. 1983 Jun 11;1(8337):1326. [PubMed]
  • Evans MJ, Cabral LJ, Stephens RJ, Freeman G. Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. Exp Mol Pathol. 1975 Feb;22(1):142–150. [PubMed]
  • Sloane JP, Ormerod MG, Imrie SF, Coombes RC. The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections. Br J Cancer. 1980 Sep;42(3):392–398. [PubMed]
  • Dearnaley DP, Sloane JP, Ormerod MG, Steele K, Coombes RC, Clink HM, Powles TJ, Ford HT, Gazet JC, Neville AM. Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer. 1981 Jul;44(1):85–90. [PubMed]
  • Sloane JP, Ormerod MG. Distribution of epithelial membrane antigen in normal and neoplastic tissues and it value in diagnostic tumor pathology. Cancer. 1981 Apr 1;47(7):1786–1795. [PubMed]
  • Bramwell ME, Bhavanandan VP, Wiseman G, Harris H. Structure and function of the Ca antigen. Br J Cancer. 1983 Aug;48(2):177–183. [PubMed]